Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-κB-Related Survival Pathway Down-Regulation

Por um escritor misterioso
Last updated 22 dezembro 2024
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Arsenic trioxide (As2O3) is known to be toxic toward leukemia cells. In this study, we determined its effects on survival of human monocytic cells during macrophagic differentiation, an important biological process involved in the immune response. As2O3 used at clinically relevant pharmacological concentrations induced marked apoptosis of human blood monocytes during differentiation with either granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor. Apoptosis of monocytes was associated with increased caspase activities and decreased DNA binding of p65 nuclear factor-κB (NF-κB); like As2O3, the selective NF-κB inhibitor ( E )-3-[(4-methylphenyl)-sulfonyl]-2-propenenitrile (Bay 11-7082) strongly reduced survival of differentiating monocytes. The role of NF-κB in arsenic toxicity was also studied in promonocytic U937 cells during phorbol 12-myristate 13-acetate-induced macrophagic differentiation. In these cells, As2O3 first reduced DNA binding of p65 NF-κB and subsequently induced apoptosis. In addition, overexpression of the p65 NF-κB subunit, following stable infection with a p65 retroviral expressing vector, increased survival of As2O3-treated U937 cells. As2O3 specifically decreased protein levels of X-linked inhibitor of apoptosis protein and FLICE-inhibitory protein, two NF-κB-regulated genes in both U937 cells and blood monocytes during their differentiations. Finally, As2O3 was found to inhibit macrophagic differentiation of monocytic cells when used at cytotoxic concentrations; however, overexpression of the p65 NF-κB subunit in U937 cells reduced its effects toward differentiation. In contrast to monocytes, well differentiated macrophages were resistant to low concentrations of As2O3. Altogether, our study demonstrates that clinically relevant concentrations of As2O3 induced marked apoptosis of monocytic cells during in vitro macrophagic differentiation likely through inhibition of NF-κB-related survival pathways.
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Silymarin-Functionalized Selenium Nanoparticles Prevent LPS-Induced Inflammatory Response in RAW264.7 Cells through Downregulation of the PI3K/Akt/NF-κB Pathway
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Frontiers The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-κB-Related Survival Pathway Down- Regulation
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Cells, Free Full-Text
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
The regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-κB-Related Survival Pathway Down- Regulation
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
BioChem, Free Full-Text
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Different mechanisms of arsenic related signaling in cellular proliferation, apoptosis and neo-plastic transformation - ScienceDirect
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Crocin ameliorates arsenic trioxide‑induced cardiotoxicity via Keap1-Nrf2/HO-1 pathway: Reducing oxidative stress, inflammation, and apoptosis - ScienceDirect
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Phytochemicals targeting NF-κB signaling: Potential anti-cancer interventions - ScienceDirect
Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic  Differentiation through Nuclear Factor-κB-Related Survival Pathway  Down-Regulation
Frontiers Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids

© 2014-2024 immanuelipc.com. All rights reserved.